Page last updated: 2024-08-21

thiazolidines and piperazine

thiazolidines has been researched along with piperazine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akahoshi, F; Hayashi, Y; Sakashita, H; Yoshida, T1
Hanumappa, A; Hegde, M; Narasimhamurthy, KH; Raghavan, SC; Rangappa, KS; Sharath Kumar, KS1
Abd El Razik, HA; Abu-Serie, MM; El-Miligy, MM1

Other Studies

3 other study(ies) available for thiazolidines and piperazine

ArticleYear
[(S)-gamma-(4-Aryl-1-piperazinyl)-l-prolyl]thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors.
    Bioorganic & medicinal chemistry letters, 2007, May-01, Volume: 17, Issue:9

    Topics: Animals; Chemistry, Pharmaceutical; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Design; Enzyme Inhibitors; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Piperazine; Piperazines; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazolidines; Time Factors

2007
Synthesis and antiproliferative effect of novel 4-thiazolidinone-, pyridine- and piperazine-based conjugates on human leukemic cells.
    European journal of medicinal chemistry, 2014, Jun-23, Volume: 81

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Humans; K562 Cells; Leukemia; Membrane Potential, Mitochondrial; Molecular Structure; Piperazine; Piperazines; Pyridines; Structure-Activity Relationship; Thiazolidines; Tumor Cells, Cultured

2014
Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis.
    Future medicinal chemistry, 2017, Volume: 9, Issue:15

    Topics: Apoptosis; Binding Sites; Caspases; Cell Line, Tumor; Hep G2 Cells; Humans; Molecular Docking Simulation; Niacinamide; Phenylurea Compounds; Piperazine; Piperazines; Protein Kinase Inhibitors; Protein Structure, Tertiary; Sorafenib; Staurosporine; Thiazolidines; Vascular Endothelial Growth Factor Receptor-2

2017